Localization and expression of tissue inhibitor of metalloproteinase-1 in human urothelial cancer

Journal of Urology

Volumn 167, Issue 2 I, 2002, Pages 729-734

  Yano, Akira ^a   Nakamoto, Takahisa ^a   Hashimoto, Kunihiro ^a   Usui, Tsuguru ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder; Carcinoma; Tissue inhibitor of metalloproteinase; Urinary tract; Urothelium

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UROGENITAL TRACT TUMOR;

EID: 0036144906     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200202000-00074     Document Type: Article

References (33)

1. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
2. Matrix metalloproteinases: Biologic activity and clinical implications
3. The collagen substrate specificity of human skin fibroblast collagenase
4. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells
5. The effect of platelets on invasiveness and protease production of human mammary tumor cells
6. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
7. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
8. Growth promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells
9. Chemical synthesis and biological studies on mutated gene-control regions
10. Improved tools for biological sequence comparison
11. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas
12. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity of Swiss 3T3 cells
13. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents demerization, complex formation with interstitial collagenase, and activation of proenzyme with stromelysin
14. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions
15. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
16. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
17. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
18. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence
19. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases
20. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer
21. Urinary matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in bladder cancer
22. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma
23. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency
24. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells
25. Neutral proteinases of human mononuclear phagocytes, metalloproteinases, and tissue inhibitor of metalloproteinases
26. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity (TIMP-1/EPA)
27. Cellular distribution of transcripts for tissue inhibitor of metalloproteinase 1 and 2 in human hepatocellular carcinomas
28. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastasis
29. Expression and in-situ localization of gene coding for extracellular matrix degrading proteases in pancreatic cancer
30. Establishment of a new human urinary bladder mixed carcinoma cell line UMK-1 and its cell-density-dependent secretion of gelatinases and tissue inhibitor of metalloproteinase-1
31. K562 cells produce and respond to human erythroid potentiating activity
32. Production of mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
33. Type IV collagenase and TIMPs modulate endothelial cell morphogenesis in vitro